Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Zhong Lun Law Firm
On October 23, 2017, the China Food and Drug Administration ("CFDA") released the revised Administrative Measures for Drug Registration ("Draft for Comment") for public comment.
Jincheng Tongda & Neal
China has been endeavoring to make comprehensive and fundamental regulatory reform of drug and medical device, in particular in the drug and medical device registration system.
CMS Cameron McKenna Nabarro Olswang LLP
After the State Council issued the Opinions on Deepening the Reform of Examination and Approval System and Encouraging Innovation of Drugs and Medical Devices ("Opinions") on 8 October 2017, ...
Ropes & Gray LLP
The opinions will create a level playground for R&D-focused drug and device companies, at home and abroad.
Ropes & Gray LLP
The China Food and Drug Administration (CFDA) has published its proposed amendment of the Medical Device Regulations (MDR), previously known as the State Council Order # 650, for public comments.
Ropes & Gray LLP
The China Food and Drug Administration (CFDA) published its proposed amendment of the Drug Administration Law (DAL) and the Drug Registration Rules (DRR) for public comments. This Alert summarizes the key changes.
Ropes & Gray LLP
In addition, the Final Policy attempts to strike a balance between the potentially conflicting interest of innovative and generic drug manufacturers.
McDermott Will & Emery
Hospitals in China differ greatly from those in the west with respect to their relationships with physicians and patients; but they also share some of the same legal challenges faced by western hospitals.
Ropes & Gray LLP
In China, medical devices are divided into three regulatory classes based on the identified risks associated with the devices.
Global Advertising Lawyers Alliance (GALA)
The Tribunal made an award on Jurisdiction and Admissibility in which it addressed only the three bifurcated objections raised by the Australian government.
Nishith Desai Associates
The landscape of the Indian healthcare industry is in constant flux, with new developments taking place on an almost daily basis in terms of both technology and law.
Khaitan & Co
The Food Safety and Standards Authority of India (FSSAI) recently released guidelines (Guidelines) on food recall by food business operators (FBO) pursuant to the Food Safety and Standards (Food Recall Procedure) Regulations, 2017, (Regulations).
S.S. Rana & Co. Advocates
To patronize growth through innovation and entrepreneurship, the Government of India through its pragmatic approach introduced the Startup India Scheme.
Singh & Associates
In October 2017, the first National Ethical Guidelines for Biomedical Research Involving Children has been published by the division of publication and information on behalf of the Secretary...
Singh & Associates
On October 03, 2017, WIPO and the research-based pharmaceutical industry announced launch of a new partnership to promote the accessibility of patent information for health agencies tasked....
Singh & Associates
On October 18, 2017, the US FDA approved Yescarta (Axicabtagene Ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or ...
S.S. Rana & Co. Advocates
In order to ensure better management and effective control regarding the standards to be maintained in various products available in the market the Food Safety Standards Authority of India has issued the following regulations:
Singh & Associates
Global Hunger Index (GHI) is designed to comprehensively measure and track hunger score globally and by country and region.
Singh & Associates
According to the new Global TB Report 201716 released by the WHO in October 2017, global efforts to combat TB have saved an estimated 53 million lives since 2000 and reduced the TB mortality rate by 37%.
Singh & Associates
NPPA, a regulatory body under Department of Pharmaceuticals, Government of India, is authorized to fix/ revise the prices of controlled bulk drugs and formulations and to enforce prices...
Latest Video
Most Popular Recent Articles
Norton Rose Fulbright Australia
Businesses in food and agriculture industries should be particularly alive to the risk of slavery in their supply chains.
Carroll & O'Dea
The appeal addressed how the trial judge could properly choose between competing expert opinions on mental harm.
Norton Rose Fulbright Australia
The article considers the responses to some of the key recommendations and potential implications of these responses.
Holman Webb
A genomic profile may help a doctor make personalised health decisions, but also raises a number of ethical challenges.
Holman Webb
Future action for non-compliance with the ACL in the marketing of therapeutic goods may result in much higher penalties.
Holman Webb
The Appeal decision confirms the need to understand medical malpractice and civil liability policy terms and conditions.
Carroll & O'Dea
This article focuses on some information provision issues addressed in the new ethical guidelines on the use of ART.
Carroll & O'Dea
The balancing exercise between confidentiality and the patient's potential risk to the community has become no easier.
Sparke Helmore Lawyers
A string of successful prosecutions by the Food Authority should alert businesses to comply with food safety obligations.
Carroll & O'Dea
Despite the popularity of cosmetic procedures, the industry in Australia is less regulated than other areas of medicine.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter